Nisa Investment Advisors LLC Has $10.61 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Nisa Investment Advisors LLC increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 0.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 115,363 shares of the medical device company’s stock after acquiring an additional 830 shares during the quarter. Nisa Investment Advisors LLC owned about 0.06% of Cooper Companies worth $10,605,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Ashton Thomas Securities LLC acquired a new position in shares of Cooper Companies in the 3rd quarter worth approximately $25,000. Covestor Ltd lifted its holdings in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares during the period. Brown Brothers Harriman & Co. boosted its position in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 275 shares during the last quarter. Friedenthal Financial acquired a new stake in Cooper Companies during the 3rd quarter worth about $50,000. Finally, Cromwell Holdings LLC bought a new position in shares of Cooper Companies in the 3rd quarter worth about $52,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $95.68 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm’s 50-day simple moving average is $95.99 and its 200 day simple moving average is $99.14. The stock has a market cap of $19.10 billion, a price-to-earnings ratio of 49.07, a PEG ratio of 2.42 and a beta of 0.99. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.87 earnings per share. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Wells Fargo & Company increased their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.